The AI practice at Fasken pairs the bench strength of 7 national offices and the experience of its team to advise startups and household name tech multinationals across such sectors as insurance, mining, aerospace and pharmaceuticals. The group brings strength to assisting with copyright and privacy issues related to datasets and AI outputs and legislation governing the development and use of AI systems. In addition, the team guides AI corporates throughout the entire life cycle of their businesses, from company formation and product development to M&A and going public transactions. The practice is headed by Ariel Laver in Vancouver, who brings expertise to assisting startups with financing transactions, and tech privacy compliance and risk management expert Christopher Ferguson and Andrew Alleyne, who specializes in the tech elements of M&A transactions, in Toronto.

Legal 500 Editorial commentary

Key clients

  • Canaccord Genuity Corp.
  • Maxa AI
  • Valence Discovery
  • Quandri Technologies
  • Walter Software
  • Streamforge

Work highlights

  • Advised Parallel Studios, a developer of blockchain-enabled video games in its $35m bridge financing round from US Investors.
  • Advised Good Chemistry, a computational chemistry company in its acquisition by a subsidiary of SandboxAQ by way of a plan of arrangement.
  • Advised Valence Discovery, a Montreal-based startup in the artificial intelligence (AI) drug-discovery space, in its $47.5m acquisition by Recursion Pharmaceuticals, an American biotech company.

Practice head

The lawyer(s) leading their teams.

Ariel Laver, Chris Ferguson, Andrew Alleyne